Ultrasonography is a valuable tool in the diagnosis and management of peripheral neuropathies. This non-invasive imaging modality offers real-time visualization of the peripheral nerves, allowing for accurate assessments of the nerve morphology and pathology. Ultrasound can detect various abnormalities, including nerve enlargement, focal constriction, and intra- and extra-neural lesions. In particular, this modality has proven useful in evaluating compressive neuropathies such as carpal tunnel syndrome and cubital tunnel syndrome. Despite its several advantages, ultrasound should be used in conjunction with other diagnostic modalities, such as physical examinations or electromyography, to confirm the diagnosis and guide treatment.

Purpose: : This methodological study aimed to develop a practical, evidence-based protocol for External Ventricular Drainage (EVD) management, toward preventing complications, reducing morbidity and mortality, and shortening hospital stays. Methods: : The study was conducted between June and October, 2023. A multidisciplinary panel—comprising eight ICU nurses with ≥5 years’ experience, three neurosurgery residents, and two methodology experts—developed a preliminary protocol. Ninety-three draft recommendations were assessed for content validity by three neurosurgeons using the Content Validity Index (CVI); items with CVI = 1.0 were retained, and others were revised or removed. Seventeen additional recommendations derived from the international guidelines were incorporated, yielding 110 items. Ten ICU nurses then evaluated the appropriateness and applicability of the RAND/UCLA Appropriateness Method (RAM). Descriptive statistics were calculated using SPSS version 27.0. Results: : Of the 110 recommendations, 9 were retained without change, 16 were revised, 3 were merged, and 3 were deleted. After consolidation, the final protocol comprised 104 recommendations categorized into four phases: preoperative, intraoperative, postoperative, and removal. Recommendation strength was graded using the modified GRADE system: Class I (n = 65), IIa (n = 24), IIb (n = 13), and III (n = 2). Validity was appraised using the AGREE II instrument, with a mean overall rating of 6.3 on a 7-point scale. Conclusion : The resulting protocol provides a practical, evidence-based guideline for EVD care and may serve as a methodological reference for the development of future clinical guidelines.

Although aspartate aminotransferase (AST) is a serum marker of hepatocellular damage in chronic hepatitis, it is difficult to interpret very high AST levels with concurrent low alanine aminotransferase (ALT) levels. Macro-AST is an immunoglobulin-AST complex that can present as aberrant high enzymatic activity without significant inflammation in the liver. Two patients with chronic hepatitis B presented with disproportionate AST elevations. Their plasma samples were precipitated with polyethylene glycol (PEG) and stored at 4°C for macro-AST determinations. In Case 1, PEG precipitation showed 100% removal of AST activity, and refrigerated storage resulted in a ~70% decline over seven days, confirming macro-AST. In Case 2, both tests showed minimal changes, suggesting that macro-AST was unlikely. The AST levels normalized after antiviral therapy, suggesting immune-active hepatitis as the probable cause, but the other contributing factors could not be completely excluded. The abrupt decrease in AST activity after PEG precipitation and during refrigeration storage suggests that relatively high AST values compared to ALT might be attributed to the presence of macro-AST.These non-invasive methods for detecting macroenzymes might help the patient avoid unnecessary further work-ups.

Background: Research on the relationship between the progression of interstitial lung abnormalities (ILA) and serum biomarkers, including white blood cell differential counts and Krebs von den Lungen-6 (KL-6), is limited. This study aimed to examine the clinical characteristics of patients with ILA and evaluate the association between disease progression and serum biomarkers. Methods: This retrospective cohort study analyzed data from 159 patients (63 with ILA and 74 with interstitial lung diseases) between October 2021 and September 2022. Data collected included clinical characteristics, pulmonary function tests, chest computed tomography (CT), complete blood cell counts, and KL-6 levels. In 52 of these patients who had previously undergone chest CT, the utility of serum biomarkers in reflecting radiologic progression was assessed using receiver operating characteristic curve analysis. Results: Patients with ILA exhibited clinical characteristics similar to those with idiopathic pulmonary fibrosis. Serum KL-6 levels did not correlate with forced vital capacity or diffusing capacity of the lung for carbon monoxide in patients with ILA. Among the 52 patients with ILA, 13 demonstrated radiologic progression. Serum KL-6 displayed moderate predictive performance, with area under the curves ranging from 0.57 to 0.89 (p=0.014) for radiologic progression. Levels of KL-6 greater than 400 U/mL were more frequently observed in patients with radiologic progression (61.5% vs. 20.5%, p=0.006). In multivariate analysis, age and KL-6 were independently associated with radiologic progression in patients with ILA. Conclusion Serum KL-6 levels may serve as a potential indicator of ILA progression in asymptomatic patients. Those with KL-6 levels exceeding 400 U/mL should be closely monitored for radiologic progression.

Objective: This study compared clinical and cosmetic outcomes of cranioplasty using customized three-dimensional (3-D) printed implants versus autologous bone in patients with aneurysmal subarachnoid hemorrhage (aSAH) after decompressive craniectomy (DC). Methods: We retrospectively reviewed 50 patients who underwent cranioplasty after DC for aSAH between July 2018 and December 2023. Patients were divided into the three-dimensional cranioplasty(3-DC, n=26) and autologous bone cranioplasty (AC, n=24) groups. Demographics, aneurysm characteristics, surgical parameters, morphometric analysis of defect coverage, complications, and functional outcomes assessed by the modified Rankin Scale (mRS) were compared. Results: A total of 54 hemispheres underwent cranioplasty. Compared with AC, the 3-DC group had larger defects but achieved higher coverage (96.7% vs. 93.4%, p=0.044) and smaller residual defects (338.7±274.2 mm² vs. 528.5±331.3 mm², p=0.049). Complication rates were lower in 3-DC (9 cases) than AC (15 cases, p=0.0994). Wound dehiscence and fluid collection were more frequent with 3-DC, while bone flap resorption and epidural abscess occurred only with AC. Revision surgery was required in six patients, five initially treated with autologous bone. Neurological outcomes (mRS) were maintained or improved in both groups. Conclusions In aSAH patients undergoing cranioplasty after DC, customized 3-D printed implants achieved significantly better anatomical restoration and showed a numerical trend toward fewer complications compared with autologous bone. While AC remains feasible, its risks of resorption and infection often necessitate revision. 3-D printed implants may be considered a reasonable alternative, particularly in aSAH patients at higher risk of complications.

This study aimed to identify factors associated with medication near-misses among nurses. Methods:This cross-sectional study included 146 nurses with at least 3 months of clinical experience at a tertiary hospital or general hospital in B metropolitan city. Data were collected from June 17 to July 5, 2024, using self-reported questionnaires assessing medication safety competence, organizational communication satisfaction, safety climate, and medication near-miss frequency within the past 3 months. IBM SPSS/WIN 29.0 program was used for analysis; negative binomial regression was applied to address overdispersion in medication near-miss frequency. Results: Within the past 3 months, 72.6% of the participants reported at least one medication near-miss. Higher medication safety competence (Incidence Rate Ratio, IRR=0.98, 95% Confidence Interval, CI=0.96~0.99), higher safety climate (IRR=0.98, 95% CI=0.96~0.99), and longer total clinical experience (IRR=0.93, 95% CI=0.89~0.98) were significantly associated with lower medication near-miss frequency.Medication near-miss frequency varied significantly by work unit, highest among nurses in medical wards.However, organizational communication satisfaction showed no significant association with medication near-miss frequency. Conclusion: Medication near-misses were found to be highly prevalent among nurses in clinical settings. To reduce medication near-misses, it is essential to enhance medication safety competence and safety climate and to implement organizational strategies tailored to nurses’ experience level and work unit.

Background: Identifying the risks related to the complications of electrical cardioversion (ECV) can alert the determinaton of rhythm control in patients with atrial fibrillation (AF). Methods: We retrospectively reviewed 1,058 patients who underwent ECV for persistent or long-standing persistent AF/atrial flutter (AFL) from multiple centers. Patients were classified into the no-complication (1,023 patients) and complication (35 patients) groups based on the following major complications: stroke and/or systemic embolism (SSE), myocardial infarction, major bleeding, implantation of cardiac implantable electronic devices, ventricular tachycardia/fibrillation, and death at 1 year follow-up after ECV. Results: Compared with the no-complication group, the complication group exhibited a higher proportion of female patients (37% vs. 22%), as well as a higher proportion of patients with older age (67 ± 11 vs. 61 ± 10 years), diabetes mellitus (DM) (49% vs. 24%), heart failure (HF) (49% vs. 30%), SSE (23% vs. 9%), high CHA 2 DS 2 -VASc (CV) score (3.6 ± 1.8 vs.2.2 ± 1.4), low left ventricular ejection fraction (LVEF) (50 ± 16% vs. 58 ± 21%), and high left atrial volume index (LAVI) (51 ± 26 vs. 40 ± 20 mL/m 2 ). Class I and III antiarrhythmics were less prescribed in the complication group than in the no-complication group (57% vs.76%). Univariate analysis for complications revealed age (≥ 65 years), female sex, DM, HF, SSE, LVEF (< 50%), LAVI (≥ 40 mL/m 2 ), CV score (≥ 3), bradycardia on Holter (< 60/min), and no antiarrhythmics as risk factors. Among these, multivariate analysis revealed clinical significance of female sex and SSE. Conclusion Female sex and a history of SSE were the most important risk factors of complications in patients with persistent or long-standing persistent AF/AFL who underwent ECV.